Research project to develop temperature-adjustable retina laser launched

Article

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research.

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research. Collaboration partners on the project include Carl Zeiss Meditec, the Medical Laser Center, Lübeck, the Institute of Biomedical Optics of the University of Lübeck and the Eye Clinic of the University Hospital of Schleswig-Holstein, Germany.

The research project aims to develop a method for targeting precise doses of laser radiation to specific areas within the eye. The doses will be set automatically, to be as low as possible to reduce or eliminate side effects whilst being high enough to be optimally effective to conduct the treatment. The adjustable-temperature laser is intended to treat diseases such as diabetic retinopathy that affect a large portion of the retina.

The project was selected as the winner of the Ministry for Education and Research's "Innovation Competition for the Advancement of Medical Technology", and is anticipated to run for three years.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.